Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis
2014 · Blood · 461 citations
https://doi.org/10.1182/blood-2014-05-578963
R
Reem Karmali
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
357
Papers
4.2K
Citations
32
h-index
87
i10-index
Reem Karmali is an academic researcher from Northwestern University. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & CAR-T cell therapy research & Chronic Lymphocytic Leukemia Research. The author has an h-index of 32, co-authored 304 publications.
ORCID: 0000-0003-0984-4376Papers by this author
worksSurvival Outcomes of Younger Patients With Mantle Cell Lymphoma Treated in the Rituximab Era
2019 · Journal of Clinical Oncology · 94 citations
https://doi.org/10.1200/jco.18.00690
Histiocytic Neoplasms, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
2021 · Journal of the National Comprehensive Cancer Network · 68 citations
https://doi.org/10.6004/jnccn.2021.0053
Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study
2023 · Journal of Hematology & Oncology · 43 citations
https://doi.org/10.1186/s13045-023-01508-3
Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy
2024 · Blood Advances · 23 citations
https://doi.org/10.1182/bloodadvances.2023011996
Impact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study
2023 · Journal of Hematology & Oncology · 18 citations
https://doi.org/10.1186/s13045-023-01448-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat